Reducing Proviral HIV DNA With Interferon-a
NCT02227277
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
54
Enrollment
OTHER
Sponsor class
Conditions
HIV
HIV/AIDS
Interventions
DRUG:
Peg-IFN-α2b
Sponsor
The Wistar Institute
Collaborators
[object Object]
[object Object]
[object Object]